Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Kite Pharma’s Viral Vector Manufacturing Facility, California

The new facility will manufacture viral vectors for cell therapy production as well as the company’s CAR-T-cell therapy, Yescarta®. Image courtesy of AJC1.



  • Kite Pharma’s Viral Vector Manufacturing Facility, California
  • Kite Pharma’s Viral Vector Manufacturing Facility, California
  • Kite Pharma’s Viral Vector Manufacturing Facility, California
Close
Close
Close

Go Top